Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction

Recruiting N/A Interventional Study
Intravascular Imaging and Microvascular Obstruction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
90 (estimated)
Sponsor
Harbin Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is a prospective, single-center, randomized controlled clinical trial. Ninety patients with anterior wall ST-segment elevation myocardial infarction (STEMI) who are planned for primary percutaneous coronary intervention (PCI) within 6 hours of symptom onset will be screened. Patients with inclusion criteria and without exclusion criteria will be randomized into three groups in a 1:1:1 r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Clinical Inclusion Criteria: 1. Subjects aged ≥18 years; 2. Initial diagnosis of anterior wall ST-segment elevation myocardial infarction, with symptoms occurring within 6 hours, and undergoing primarypercutaneous coronary intervention (PCI); 3. Subjects (or legal representativ…
Contacts

Xingtao Huang, MD

+86-13796626722

dr_huangxingtao@163.com

CONTACT